Revisiting the Elusive Hepatitis C Vaccine

The impactful discovery and subsequent characterisation of hepatitis C virus (HCV), an RNA virus of the flavivirus family, led to the awarding of the 2020 Nobel Prize in Physiology or Medicine to Harvey J. Alter, Michael Houghton and Charles M. Rice [...].

Saved in:
Bibliographic Details
Published in:Vaccines (Basel) 2021-02, Vol.9 (2), p.114
Main Authors: Todryk, Stephen M, Bassendine, Margaret F, Bridge, Simon H
Format: Article
Language:English
Subjects:
Animal models
Antibodies
Antigens
Apolipoprotein E
CD81 antigen
Cell culture
Chronic infection
Cirrhosis
Density
Fibrosis
Genetic diversity
Genetic variance
Global health
Glycoproteins
Glycosaminoglycans
Hepatitis
Hepatitis C
Immune response
In vitro methods and tests
Infections
Lipids
Lipoprotein receptors
Lipoproteins
Liver
Liver cancer
Lymphocytes
Melanoma
Morbidity
Moving targets
n/a
Nobel prizes
Pattern recognition
Pattern recognition receptors
Proteins
Public health
Receptors
Ribonucleic acid
RNA
RNA polymerase
Scavenger receptors
Severe acute respiratory syndrome coronavirus 2
TLR7 protein
Toll-like receptors
Vaccines
Viruses
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The impactful discovery and subsequent characterisation of hepatitis C virus (HCV), an RNA virus of the flavivirus family, led to the awarding of the 2020 Nobel Prize in Physiology or Medicine to Harvey J. Alter, Michael Houghton and Charles M. Rice [...].
ISSN:2076-393X
2076-393X
DOI:10.3390/vaccines9020114